Status:
RECRUITING
The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Status Epilepticus
Ictal-interictal Continuum
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The investigators propose a prospective study of 20 control subjects and 180 consecutive patients with possible non-convulsive status epilepticus (NCSE). The investigators will obtain three functional...
Eligibility Criteria
Inclusion
- \- The patient has possible non-convulsive status epilepticus with scalp or invasive EEG with ictal-interictal continuum patterns on EEG
Exclusion
- The patient has a contra-indication for MRI such as metal implants
- The patient has contrast sensitivity
- The patiensuffers from claustrophobia or cannot tolerate confinement during PET-MRI scanning procedures
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06017973
Start Date
October 1 2023
End Date
September 30 2027
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven, department of Neurology
Leuven, Belgium, 3000